三氧化二砷联合抗坏血酸对骨髓瘤细胞增殖与凋亡的作用
被引量:1
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2005年第10期625-627,共3页
Chinese Journal of Hematology
基金
国家自然科学基金资助项目(30070323)
参考文献5
-
1Grad JM, Bahlis NJ, Krett N, et al. Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells.Mol Cancer Ther,2003,2:1155-1164.
-
2Hussein MA. Trials of arsenic trioxide in multiple myeloma. Cancer Control, 2003,10:370-374.
-
3Chen Q, Gong B, Ashraf S, et al. Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma. Blood, 2001,98:2183-2192.
-
4Woo SH, Park IC, Park M J, et al. Arsenic trioxide induces apoptosis through areactive oxygene species-dependent pathway and loss of mitochondrial membrane potential in Hela cell. Int J Oncol, 2002, 21:57-63.
-
5Dai J, Waxman RS, Waxman S, et al. Malignant cell can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathion redox system. Blood, 1999,93:268-277.
同被引文献9
-
1宋艳斌,马文丽,冯春琼,毛向明,石嵘,张宝,郑文岭.应用RNA干扰技术抑制K562细胞BCR-ABL基因表达及诱导细胞凋亡[J].基础医学与临床,2005,25(7):620-623. 被引量:6
-
2张卓琦,曹希传,朱文玲.三氧化二砷抑制血管平滑肌细胞及巨噬细胞中转染的肿瘤坏死因子-α启动子活性[J].基础医学与临床,2006,26(1):74-78. 被引量:3
-
3Yoon P, Giafis N, Smish J, et al. Activation of mammalian target of rapamycin and the p70 S6 kinase by arsenic trioxide in BCR-ABL-expressing cells [ J ]. Mol Cancer Ther, 2006,5( 11 ) :2815 -2823.
-
4Grad JM, Bahlis NJ, Krett N, et al. Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells[ J ]. Mol Cancer Ther,2003,11 ( 2 ) : 1155 - 1165.
-
5Sanz MA. Treatment of acute promyelocytic leukemia[ J]. Hematol Am Soc Hematol Educ Program,2006,1:47 -55.
-
6Jazirehi AR, Ng CP, Gan Xiao-Hu, et al. Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis facter-related apoptosis-inducing ligand-mediated(TRAIL) apoptosis [ J ]. Clin Cancer Res ,2001,11:3874 - 3884.
-
7Chen Dong, Chan Rui, Waxman S, et al. Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2,-terminal kinase and up-regulation of death receptors[J]. Cancer Res,2006,66(23) :11416 - 11423.
-
8Park IC, Park MJ, Woo SH, et al. Tetra arsenic oxide induces apoptosis in U937 leukemic cells through are active oxygen species-dependent pathway [ J ]. Int J Oncol, 2003,23 (4) :9431.
-
9Gong Bendi, Almasan A. Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5mediate the apoptotic signaling induced by ionizing radiation in leukemia cells[J]. Cancer Res, 2000, 60(15) : 5754 -5760.
二级引证文献3
-
1周秀杰,周郁鸿.三氧化二砷(As_2O_3)治疗多发性骨髓瘤机理的研究进展[J].中医学报,2010,25(6):1052-1054. 被引量:3
-
2何靖,陈鹏,胡莉文,古学奎.三氧化二砷治疗多发性骨髓瘤的研究进展[J].齐鲁医学杂志,2017,32(1):117-119. 被引量:7
-
3柯金勇,汪玉芳,陆亚岚,张欣,柯善栋.SOX2蛋白及趋化相关基因CCR1、CCR2、MCP-1影响骨髓瘤细胞生物学特性的机制[J].海南医学,2018,29(17):2377-2380. 被引量:1
-
1翟勇平,刘海宁,于亚平,宋萍,周晓钢,李锋,王学文.BLTD方案治疗24例难治复发性多发性骨髓瘤[J].中华血液学杂志,2007,28(4):270-271. 被引量:5
-
2陈精予,刘昌发.沙立度胺联合化疗多发性骨髓瘤13例分析[J].中国误诊学杂志,2007,7(15):3646-3647. 被引量:2
-
3马洪,施守勤,施婺丹,程惠馨.长春新碱、米托蒽醌、环磷酰胺和地塞米松治疗复发性多发性骨髓瘤[J].铁道医学,1999,27(1):56-57.
-
4陈小华.三氧化二砷联合维生素C治疗难治性及复发性多发性骨髓瘤疗效观察[J].山东医药,2008,48(25):83-84. 被引量:2
-
5万楚成,郭仁慈,夏云金,章正华.VAD方案及异搏定治疗难治性及复发性多发性骨髓瘤11例疗效观察[J].中国实用内科杂志,1995,15(9):541-542. 被引量:1
-
6黄亚丽,谢治军,黄刚,廖建军,韦湘,黄继贤,杨丽萍.亚砷酸联合反应停、维生素C治疗难治性复发性多发性骨髓瘤[J].哈尔滨医药,2016,36(2):117-118. 被引量:1
-
7赵小亭,李葳,郭良耀.沙利度胺联合VAD方案治疗难治、复发性多发性骨髓瘤临床分析[J].中国实用医药,2006,1(6):68-69.
-
8何娟,李洁,吕晓毅,王柏勋,翟明.硼替佐米治疗难治陛复发性多发性骨髓瘤疗效分析[J].白血病.淋巴瘤,2008,17(5):359-360.
-
9马俊霞,裴仁治,刘旭辉,张丕胜,杜小红,曹俊杰.反应停治疗难治性和复发性多发性骨髓瘤临床疗效观察[J].浙江临床医学,2007,9(1):75-76. 被引量:1
-
10姜志民.沙利度胺加地塞米松治疗复发性多发性骨髓瘤的临床观察[J].昆明医学院学报,2009,30(1):121-123.